194 related articles for article (PubMed ID: 24070710)
1. Association between MDR1 C3435T polymorphism and risk of breast cancer.
Wang Z; Wang T; Bian J
Gene; 2013 Dec; 532(1):94-9. PubMed ID: 24070710
[TBL] [Abstract][Full Text] [Related]
2. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
3. Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis.
Zhong S; Xu J; Li W; Chen Z; Ma T; Zhao J
Gene; 2013 Sep; 527(2):510-5. PubMed ID: 23845785
[TBL] [Abstract][Full Text] [Related]
4. Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population.
Tatari F; Salek R; Mosaffa F; Khedri A; Behravan J
DNA Cell Biol; 2009 May; 28(5):259-63. PubMed ID: 19388849
[TBL] [Abstract][Full Text] [Related]
5. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
6. MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.
Sheng X; Zhang L; Tong N; Luo D; Wang M; Xu M; Zhang Z
Mol Biol Rep; 2012 Jul; 39(7):7237-49. PubMed ID: 22311042
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
8. The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.
Ayaz G; Batar B; Kanigur G; Guven M; Onaran I; Karadag B; Ilerigelen B; Dirican A; Ulutin T
Gene; 2013 Sep; 527(1):301-5. PubMed ID: 23816407
[TBL] [Abstract][Full Text] [Related]
9. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis.
Tazzite A; Kassogue Y; Diakité B; Jouhadi H; Dehbi H; Benider A; Nadifi S
BMC Genet; 2016 Sep; 17(1):126. PubMed ID: 27580695
[TBL] [Abstract][Full Text] [Related]
10. MDR1 C3435T polymorphism and childhood acute lymphoblastic leukemia susceptibility: an updated meta-analysis.
Yue Q; Xiong B; Chen L; Chen Y; Bu F; Liu X; Cheng F
Biomed Pharmacother; 2015 Feb; 69():76-81. PubMed ID: 25661341
[TBL] [Abstract][Full Text] [Related]
11. MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.
Wang J; Wang B; Bi J; Li K; Di J
J Cancer Res Clin Oncol; 2012 Jun; 138(6):979-89. PubMed ID: 22358302
[TBL] [Abstract][Full Text] [Related]
12. Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population.
Skalski D; Wendorff J; Romanowicz H; Rysz A; Marchel A; Stasiołek M; Smolarz B
Acta Neurol Belg; 2017 Mar; 117(1):153-158. PubMed ID: 27534401
[TBL] [Abstract][Full Text] [Related]
13. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
14. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
15. ABCB1-C3435T polymorphism and breast cancer risk: a case-control study and a meta-analysis.
Sharif A; Kheirkhah D; Reza Sharif M; Karimian M; Karimian Z
J BUON; 2016; 21(6):1433-1441. PubMed ID: 28039704
[TBL] [Abstract][Full Text] [Related]
16. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
18. VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls.
Gu D; Wang M
Breast Cancer Res Treat; 2011 Jan; 125(2):489-93. PubMed ID: 20563637
[TBL] [Abstract][Full Text] [Related]
19. Influence of Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the Incidence of Breast Cancer--a Case-Control Study in Jordan.
Abuhaliema AM; Yousef AM; Elmadany NN; Bulatova NR; Awwad NM; Yousef MA; Al Majdalawi KZ
Asian Pac J Cancer Prev; 2016; 17(1):261-6. PubMed ID: 26838221
[TBL] [Abstract][Full Text] [Related]
20. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis.
Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G
Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
